Non Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients Scheduled for Electrical Cardioversion: A Real-Life Propensity Score Matched Study.

Anna RagoEnrica PezzulloMarco Malvezzi Caracciolo d'AquinoGabriella ScognamiglioValentina Maria CasoFrancesco MartoneEmilio AttenaValentina ParisiAntonio D'OnofrioPaolo GolinoGerardo NigroVincenzo Russo

Published in: Journal of blood medicine (2021)

We showed a safe and effective clinical profile of NOACs among AF patients scheduled for electrical cardioversion in real-life setting. Patients on NOACs therapy showed a lower discontinuation rate compared to those on VKAs.

Keyphrases

atrial fibrillation
end stage renal disease
oral anticoagulants
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
heart failure
acute coronary syndrome
left atrial
coronary artery disease
percutaneous coronary intervention
left atrial appendage
smoking cessation